These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38447413)

  • 41. "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
    Dolan SB; Chen Z; Huang R; Gatch MB
    Neuropharmacology; 2018 May; 133():171-180. PubMed ID: 29378213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.
    Price LH; Ricaurte GA; Krystal JH; Heninger GR
    Arch Gen Psychiatry; 1989 Jan; 46(1):20-2. PubMed ID: 2562914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L; Chandler C; Sanders G
    Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.
    Cadet JL; Krasnova IN; Jayanthi S; Lyles J
    Neurotox Res; 2007 Apr; 11(3-4):183-202. PubMed ID: 17449459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.
    Murnane KS; Murai N; Howell LL; Fantegrossi WE
    J Pharmacol Exp Ther; 2009 Nov; 331(2):717-23. PubMed ID: 19684254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.
    Daumann J; Schnitker R; Weidemann J; Schnell K; Thron A; Gouzoulis-Mayfrank E
    Neuroreport; 2003 Oct; 14(15):1983-7. PubMed ID: 14561934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.
    Sealover NR; Felts B; Kuntz CP; Jarrard RE; Hockerman GH; Lamb PW; Barker EL; Henry LK
    Biochem Pharmacol; 2016 Nov; 120():46-55. PubMed ID: 27638414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD; Vonmoos M; Fürst M; Schädelin K; Kraemer T; Baumgartner MR; Seifritz E; Quednow BB
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
    Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
    J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?
    Dias da Silva D; Carmo H; Silva E
    Arch Toxicol; 2013 Jan; 87(1):111-22. PubMed ID: 23001138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.
    Fantegrossi WE; Ciullo JR; Wakabayashi KT; De La Garza R; Traynor JR; Woods JH
    Neuroscience; 2008 Jan; 151(2):533-43. PubMed ID: 18082974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
    Parrott AC
    J Psychopharmacol; 2005 Jan; 19(1):71-83. PubMed ID: 15671132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
    Zacny JP; Virus RM; Woolverton WL
    Pharmacol Biochem Behav; 1990 Mar; 35(3):637-42. PubMed ID: 1971112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
    Bershad AK; Miller MA; Baggott MJ; de Wit H
    J Psychopharmacol; 2016 Dec; 30(12):1248-1258. PubMed ID: 27562198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW; Stone DM; Stahl DC; Hanson GR
    NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users.
    McCann UD; Peterson SC; Ricaurte GA
    Neuropsychopharmacology; 2007 Aug; 32(8):1695-706. PubMed ID: 17203011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.